Key statistics
On Saturday, Can Fite Biopharma Ltd (CANF:ASQ) closed at 1.98, 9.39% above its 52-week low of 1.81, set on Oct 27, 2023.
52-week range
Open | 2.05 |
---|---|
High | 2.13 |
Low | 1.87 |
Bid | 1.93 |
Offer | 2.09 |
Previous close | 2.02 |
Average volume | 96.40k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Sep 21 2024.
More ▼
- Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health
- Can-Fite Announces Exercise of Warrants for Approximately $5.0 Million in Gross Proceeds
- Can-Fite Provides Namodenoson Patent Update
- Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on August 8
- Can-Fite Applies for FDA Orphan Drug Designation for Namodenoson in the Treatment of Pancreatic Cancer
- Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson
- Can-Fite Announces Exercise of Warrants for Approximately $3.0 Million in Gross Proceeds
More ▼